AndreaBozzo/ceres-open-data-index huggingface dataset:
Climate Shield Cutthroat Trout (0% Brook Trout), 2080 (Feature Layer)

This feature class represents the end-of-century (2070-2099) scenario for cutthroat trout, derived from the Climate Shield fish distribution models. These models provide stream-specific probabilistic predictions about the occurrence of juvenile bull trout and cutthroat trout in association with three different scenarios for climate change and brook trout invasions. These datasets indicate all potential cold-water habitats less than 11 degrees Celsius. The attribute fields CT_0BRK - CT_100BRK indicate the probabilities of cutthroat trout occurrence within a cold-water habitat based on the prevalence of brook trout at 0%, 25%, 50%, 75%, or 100% of the sites within a habitat. The probabilities were predicted using the Climate Shield native trout models developed from known species occurrence in greater than 500 cold-water streams. The stream centerlines were based on the National Hydrography Dataset (NHD) but were modified for purposes of modeling and cross-walking to other datasets.
Treatment Episode Data Set: Discharges (TEDS-D-2008)

<p>The Treatment Episode Data Set -- Discharges (TEDS-D) is a national census data system of annual discharges from substance abuse treatment facilities. TEDS-D provides annual data on the number and characteristics of persons discharged from public and private substance abuse treatment programs that receive public funding. Data collected both at admission and at discharge is included. The unit of analysis is a treatment discharge. TEDS-D consists of data reported to state substance abuse agencies by the treatment programs, which in turn report it to SAMHSA.<br />
A sister data system, called the Treatment Episode Data Set -- Admissions (TEDS-A), collects data on admissions to substance abuse treatment facilities. The first year of TEDS-A data is 1992, while the first year of TEDS-D is 2006.<br />
TEDS-D variables that are required to be reported are called the "Minimum Data Set (MDS)", while those that are optional are called the "Supplemental Data Set (SuDS)".<br />
Variables unique to TEDS-D, and not part of TEDS-A, are the length of stay, reason for leaving treatment, and service setting at time of discharge. TEDS-D also provides many of the same variables that exist in TEDS-A. This includes information on service setting, number of prior treatments, primary source of referral, sex, race, ethnicity, education, employment status, substance(s) abused, route of administration, frequency of use, age at first use, and whether methadone was prescribed in treatment. Supplemental variables include: diagnosis codes, presence of psychiatric problems, living arrangements, source of income, health insurance, expected source of payment, pregnancy and veteran status, marital status, detailed not in labor force codes, detailed criminal justice referral codes, days waiting to enter treatment, and the number of arrests in the 30 days prior to admissions (starting in 2008) .<br />
Substances abused include alcohol, cocaine and crack, marijuana and hashish, heroin, nonprescription methadone, other opiates and synthetics, PCP, other hallucinogens, methamphetamine, other amphetamines, other stimulants, benzodiazepines, other non-benzodiazepine tranquilizers, barbiturates, other non-barbiturate sedatives or hypnotics, inhalants, over-the-counter medications, and other substances.<br />
Created variables include total number of substances reported, intravenous drug use (IDU), and flags for any mention of specific substances. This study has 1 Data Set.</p>
Compound 529670: Trimethyl 4-methyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4,8-tricarboxylate

Chemical compound data from PubChem database. IUPAC Name: trimethyl 4-methyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4,8-tricarboxylate. Molecular Formula: C23H32O6. Molecular Weight: 404.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Michigan 2016 Potential Areas for Addressing Service Gaps for Opioid Treatment

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are also informed. The maps are meant to be used as a tool for policy makers to determine potentially underserved areas—not as a definitive representation of these areas.
Compound 526316: 2,3,4,9-Tetrabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,6,7,8-tetrabromodibenzofuran. Molecular Formula: C12H4Br4O. Molecular Weight: 483.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401600-T1: [Translated] NAVIGATION AND DATA ENTRY FOR OPEN INTERACTION ELEMENTS

Techniques for using open interaction elements (OIEs) in voice-enabled systems are described (2000). OIEs include multi-select and dictation fields of a user interface (1906), into which a user may enter multiple selections or free-form information. To allow the user to exit from such OIEs, that is, to change from a data entry mode to a navigation mode, multiple exit strategies may be simultaneously enabled (2004, 2006, 2008) for use by the user. For example, an explicit exit command (2020) may be available to the user, in addition to an implicit exit command (2022) or time-out exit strategy (2026). In this way, users may individually select a preferred or practical way of exiting an OIE (2028). <IMAGE>
Utility of postintubation chest radiographs in the intensive care
		  unit

Objective:
          To determine the clinical usefulness of immediate (stat) chest
				radiographs after endotracheal intubation when performed by experienced
				critical care personnel.
        
        
          Patients and methods:
          This was a prospective study. Endotracheal intubations in an
				11-bed intensive care unit and a nine-bed intermediate intensive care unit were
				included. After intubations were performed by an experienced critical care
				operator, that individual recorded demographic and procedural data, and
				predicted radiographic findings on a data collection sheet. Experience at
				intubation was stratified into four levels of lifetime experience: fewer than
				10 procedures, 10-20 procedures, 20-50 procedures, and more than 50 procedures.
				Radiographic findings evaluated included endotracheal tube position and
				procedure-related complications. The postintubation chest radiograph was then
				reviewed and the actual findings were also recorded.
        
        
          Results:
          A total of 101 evaluable intubations were recorded, two of which
				were predicted to show tube malposition. Actual radiographic findings revealed
				10 malpositions, three of which were too high and seven were too low (one at
				the level of the carina). A single witnessed aspiration that occurred during
				intubation was not radiographically apparent until 24 h later. Only the tube
				positioned at the carina was felt to be of acute clinical significance or to
				place the patient at any acute risk.
        
        
          Conclusions:
          The incidence of endotracheal tube malposition after intubation
				was underestimated. However, when performed by experienced critical care
				personnel, acutely significant malpositions were rare (one out of 101
				intubations). We conclude that, in the absence of specific pulmonary
				complications, endotracheal intubations performed by experienced operators may
				be followed by routine, rather than 'stat' chest radiographs.
DASH - Global School-based Student Health Survey (GSHS)

2003-2015. Global School dataset.  The Global School-based Student Health Survey (GSHS) was developed by the World Health Organization (WHO) in collaboration with the United Nations' UNICEF, UNESCO, and UNAIDS; and with technical assistance from CDC.  The GSHS is a school-based survey conducted primarily among students aged 13-17 years in countries around the world.  It uses core questionnaire modules that address the leading causes of morbidity and mortality among children and adults worldwide: 1) Alcohol use, 2) dietary behaviors, 3) drug use, 4) hygiene, 5) mental health, 6) physical activity, 7) protective factors, 8) sexual behaviors that contribute to HIV infection, other sexually-transmitted infections, and unintended pregnancy, 9) tobacco use, and 10) violence and unintentional injury.  This dataset contains global data from 2003 – 2015.  Additional information about the GSHS can be found at https://www.cdc.gov/gshs/index.htm.
Early bronchopulmonary involvement in Crohn disease: a case report

Background
          Bronchopulmonary manifestations of Crohn disease have been rarely described in children, including both subclinical pulmonary involvement and severe lung disease.
        
        
          Case presentation
          A 6.5-year-old girl is described with early recurrent bronchopulmonary symptoms both at presentation and in the quiescent phase of Crohn disease. Pulmonary function tests (lung volumes and flows, bronchial reactivity and carbon monoxide diffusing capacity) were normal. Bronchoalveolar cytology showed increased (30%) lymphocyte counts and bronchial biopsy revealed thickening of basal membrane and active chronic inflammation.
        
        
          Conclusions
          Clinical and histological findings in our young patient suggest involvement of both distal and central airways in an early phase of lung disease. The pathogenesis of Crohn disease-associated lung disorders is discussed with reference to the available literature. A low threshold for pulmonary evaluation seems to be advisable in all children with CD.
Compound 529148: 1-Dodecanol, DMTBS

Chemical compound data from PubChem database. IUPAC Name: tert-butyl-dodecoxy-dimethylsilane. Molecular Formula: C18H40OSi. Molecular Weight: 300.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Tetramethylpyrazine attenuates spinal cord ischemic injury due to aortic cross-clamping in rabbits

Background
          Lower limb paralysis occurs in 11% of patients after surgical procedure of thoracic or thoracoabdominal aneurysms and is an unpredictable and distressful complication. The aim of this study was to investigate the effects of tetramethylpyrazine (TMP), an intravenous drug made from traditional Chinese herbs, on the neurologic outcome and hisotpathology after transient spinal cord ischemia in rabbits.
        
        
          Methods
          Forty-five male New Zealand white rabbits were anesthetized with isoflurane and spinal cord ischemia was induced for 20 min by infrarenal aortic occlusion. Animals were randomly allocated to one of five groups (n = 8 each). Group C received no pharmacologic intervention. Group P received intravenous infusion of 30 mg·kg-1 TMP within 30 min before aortic occlusion. Group T1, Group T2 and Group T3 received intravenous infusion of 15, 30 and 60 mg·kg-1 TMP respectively within 30 min after reperfusion. In the sham group (n = 5), the animals underwent the same procedures as the control group except infrarental aortic unocclusion. Neurologic status was scored by using the Tarlov criteria (in which 4 is normal and 0 is paraplegia) at 4 h, 8 h, 12 h, 24 h, and 48 h after reperfusion. All animals were sacrificed at 48 h after reperfusion and the spinal cords (L5) were removed immediately for histopathologic study.
        
        
          Results
          All animals in the control group became paraplegic. Neurologic status and histopathology (48 h) in the Groups P, T2 and T3 were significantly better than those in the control group (P < 0.05). There was a strong correlation between the final neurologic scores and the number of normal neurons in the anterior spinal cord (r = 0.776, P < 0.01).
        
        
          Conclusion
          Tetramethylpyrazine significantly reduces neurologic injury related to spinal cord ischemia and reperfusion after aortic occlusion within a certain range of dose.
Compound 525142: Decaethylene glycol, diacetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-[2-[2-[2-[2-[2-[2-(2-acetyloxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl acetate. Molecular Formula: C24H46O13. Molecular Weight: 542.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528164: 1,3-Cyclopentadiene, 1-(2-methylpropyl)

Chemical compound data from PubChem database. IUPAC Name: 1-(2-methylpropyl)cyclopenta-1,3-diene. Molecular Formula: C9H14. Molecular Weight: 122.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525270: N'-(3-fluoro-phenyl)-N,N-dimethyl-formamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(3-fluorophenyl)-N,N-dimethylmethanimidamide. Molecular Formula: C9H11FN2. Molecular Weight: 166.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401711-T1: [Translated] BUS SYSTEM WITH LINE CONTROL DURING STANDBY

In a bus system with a low-power phase, in which bus members are in a state of reduced current consumption and leave this state when the bus lines (1, 2) are active for a longer period than a predetermined time interval, the function of the bus in the low-power phase is monitored in that a first participant (3) cyclically transmits at least one pulse on the bus during the low-power phase, which pulse has a duration that is shorter than the predetermined time interval and is received and evaluated at least by a second bus member (4) for the purpose of monitoring the bus lines (1, 2).
Patent AT-E401301-T1: [Translated] METHOD FOR THE CONTINUOUS SYNTHESIS OF MONOAKYLHYDRAZINES HAVING A FUNCTIONALIZED ALKYL GROUP

Continuous synthesis of monoalkylhydrazines (I). Continuous synthesis of monoalkylhydrazines (I) comprises: (a) reaction of anhydrous amine NH 2R (II) and monochloroamine (III) at 25-45[deg]C in alkaline medium; (b) separating the reaction mixture into organic and aqueous phases by adding anhydrous sodium hydroxide, with cooling such that the separation temperature does not exceed the boiling points of the compounds; and (c) isolating (I) from the separated organic phase. R : 2-6C alkenyl or alkynyl, 1-5C alkyl containing an imino (C=N) group, or 1-6C alkyl, linear or branched, and substituted by at least one of hydroxy, 1-6C alkoxy, C=NH, cyano, phenoxy, carboxy, 1-6C alkoxycarbonyl, phenyl or NR 3R 4; R 3 and R 41-6C alkyl or together complete a 2-6C ring.
Child and Family Services Reviews Update Volume 17, Issue 4, September 2023

This issue of Child and Family Services Reviews Update contains the following sections: CFSR Round 4 is Underway as Year 2 Approaches, Capacity Building Center for States - CFSR Round 4 Community of Practice Opportunity, Legal and Judicial Communities' Involvement Encouraged in All CFSR Phases, CB's Vision for Final Results Meetings and PIP Development, and Spanish Translations Added to Portal.

Metadata-only record linking to the original dataset. Open original dataset below.
Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies

Human tumour necrosis factor (TNF)-like weak inducer of apoptosis (hTWEAK) and two anti-hTWEAK mAbs were tested for their ability to elicit or block inflammatory responses in cultured human dermal fibroblasts and synoviocytes. Incubation with hTWEAK increased the production of prostaglandin E2, matrix metalloproteinase-1 (MMP-1), IL-6, and the chemokines IL-8, RANTES (regulated on activation, normal T expressed and secreted) and interferon-γ-inducible protein-10 (IP-10) in culture supernatant of fibroblasts and synoviocytes. In combination with TNF or IL-1β, hTWEAK further stimulated the secretion of prostaglandin E2, MMP-1, IL-6 and IL-8 up to fourfold, and IP-10 and RANTES up to 70-fold compared to TNF or IL-1β alone. An anti-hTWEAK mAb, BCB10, blocked the effects of hTWEAK, whereas hTWEAK crosslinked by the anti-hTWEAK mAb, BEB3, further stimulated the inflammatory response of fibroblasts and synoviocytes. The anti-hTWEAK mAbs were ineffective in blocking or increasing the responses of TNF or IL-1β and blocking anti-TNF mAb was ineffective in preventing the responses to TWEAK. These results were also confirmed at the RNA level for MMP-1, macrophage chemoattractant protein-1, RANTES, macrophage inflammatory protein-1α, IP-10 and IL-8. TWEAK in synergism with IL-1 and TNF may be an additional cytokine that plays a role in destructive chronic arthritic diseases.
Hospital Inpatient Discharges by Facility (SPARCS De-Identified): Beginning 2009

The Statewide Planning and Research Cooperative System (SPARCS) is a comprehensive data reporting system which collects patient level detail on patient characteristics, diagnoses, treatments, services, and charges for every hospital discharge from an Article 28 facility; ambulatory surgery discharges from hospital-based ambulatory surgery centers and all other facilities providing ambulatory surgery services; and emergency department visits in New York State.  This dataset is a summary of the  SPARCS inpatient discharge data.
Compound 526602: 1,5-Anhydro-2,6-di-O-acetyl-3,4-di-O-methyl-D-glucitol

Chemical compound data from PubChem database. IUPAC Name: (5-acetyloxy-3,4-dimethoxyoxan-2-yl)methyl acetate. Molecular Formula: C12H20O7. Molecular Weight: 276.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526286: 1,3,8-Tribromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,3,8-tribromodibenzofuran. Molecular Formula: C12H5Br3O. Molecular Weight: 404.88. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529990: Nonanoic acid, 2-bromo, methyl ester

Chemical compound data from PubChem database. IUPAC Name: methyl 2-bromononanoate. Molecular Formula: C10H19BrO2. Molecular Weight: 251.16. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401034-T1: [Translated] WASHABLE FLOOR MAT

A washable floor mat has a tufted pile textile layer ( 1 ) and an elastomer backing layer ( 2 ). The textile layer ( 1 ) includes tufts containing cotton fibres, and the backing layer ( 2 ) is made of a foamed elastomer material and includes a plurality of cleats ( 4 ) on a lower surface if the backing layer.
Patent AT-E399890-T1: [Translated] POLYPARAPHENYLENTEREPHTHALAMIDE FIBERS AND METHOD FOR PRODUCING THE SAME

A dyeable polyparaphenylene terephthalamide fiber which has been wound once after spinnig and has not been dyed yet, characterized in that it has a tensile strength of 15 g/denier or more and a crystal size (110 direction) of 30 to 55 angstroms and has no history of a treatment drying to have a water content of 8% or less, and a method for producing the same. A polyparaphenylene terephthalamide fiber which can be dyed while its properties of high strength and high modulus elasticity are maintained, and textile products made of the fiber which are dyed in a variety of colors, can be provided.
Compound 526683: Norcholic acid, acetate-methyl ester

Chemical compound data from PubChem database. IUPAC Name: methyl 3-(3,7,12-triacetyloxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)butanoate. Molecular Formula: C30H46O8. Molecular Weight: 534.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529428: 2(1H)-Naphthalenone, 4-methyl

Chemical compound data from PubChem database. IUPAC Name: 4-methyl-1H-naphthalen-2-one. Molecular Formula: C11H10O. Molecular Weight: 158.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530649: p-Toluic acid, 2,6-dimethylnon-1-en-3-yn-5-yl ester

Chemical compound data from PubChem database. IUPAC Name: 2,6-dimethylnon-1-en-3-yn-5-yl 4-methylbenzoate. Molecular Formula: C19H24O2. Molecular Weight: 284.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529949: 1-(Thiophen-3-yl)propan-2-one

Chemical compound data from PubChem database. IUPAC Name: 1-thiophen-3-ylpropan-2-one. Molecular Formula: C7H8OS. Molecular Weight: 140.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527500: Glutamic acid, N-(trifluoroacetyl)-, dibutyl ester, L-

Chemical compound data from PubChem database. IUPAC Name: dibutyl 2-[(2,2,2-trifluoroacetyl)amino]pentanedioate. Molecular Formula: C15H24F3NO5. Molecular Weight: 355.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526182: 1H-pyrrolo[2,1-c][1,4]thiazine

Chemical compound data from PubChem database. IUPAC Name: 1H-pyrrolo[2,1-c][1,4]thiazine. Molecular Formula: C7H7NS. Molecular Weight: 137.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525989: 5-Dodecyl-5-ethylthiophene

Chemical compound data from PubChem database. IUPAC Name: 2-dodecyl-5-ethylthiolane. Molecular Formula: C18H36S. Molecular Weight: 284.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525387: 2,6,6-Trimethyl-5-thiaheptane

Chemical compound data from PubChem database. IUPAC Name: 1-tert-butylsulfanyl-3-methylbutane. Molecular Formula: C9H20S. Molecular Weight: 160.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.